APPLICATION
ANDA065475
TYPE
ANDA
ORIGINAL APPROVAL
2008-08-18
LATEST ACTION
2014-12-02
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
CEFTRIAXONEDiscontinued
CEFTRIAXONE SODIUM EQ 10GM BASE/VIAL · INJECTABLE · INJECTION
Approval history
2014-12-02Labeling · Supplement 6 · standardAP
2011-07-05Labeling · Supplement 5AP
2010-06-15Labeling · Supplement 4AP
2010-04-22Labeling · Supplement 3AP
2010-03-31Labeling · Supplement 2AP
2009-07-06Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.